tirzepatide in children Study: improves blood sugar control with poorly controlled type 2 diabetes Compounding pharmacies can make tirzepatide

Common adverse effects are predominantly gastrointestinal and typically emerge during dose escalation: Nausea (affecting 2050% of users initially) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (therapeutic effect but may be excessive) Fatigue and headache Injection site reactions (redness, swelling or itching) These effects usually diminish over several weeks as the body adjusts

Time of day considerations No clinical evidence suggests that injecting in the morning versus the evening makes a meaningful difference in efficacy

Patient education programs help reduce anxiety about potential side effects

15,26 Importantly, these findings should be interpreted in the context of the observational study design